BioCentury | Feb 22, 2010
Financial News

Immune Targeting Systems financial update

...million. The extension was co-led by existing investors Novartis Venture Fund; HealthCap; and Truffle Capital. London Technology Fund...
BioCentury | Feb 18, 2010
Financial News

Immune Targeting Systems raises L8.7 million

...million). The extension was co-led by existing investors Novartis Venture Fund; HealthCap; and Truffle Capital. London Technology Fund...
BioCentury | Mar 30, 2006
Financial News

deltaDOT raises L6 million

...private round led by FF&P Private Equity. Other investors included Imperial Innovations ; NPI Ventures; London Technology Fund...
Items per page:
1 - 3 of 3
BioCentury | Feb 22, 2010
Financial News

Immune Targeting Systems financial update

...million. The extension was co-led by existing investors Novartis Venture Fund; HealthCap; and Truffle Capital. London Technology Fund...
BioCentury | Feb 18, 2010
Financial News

Immune Targeting Systems raises L8.7 million

...million). The extension was co-led by existing investors Novartis Venture Fund; HealthCap; and Truffle Capital. London Technology Fund...
BioCentury | Mar 30, 2006
Financial News

deltaDOT raises L6 million

...private round led by FF&P Private Equity. Other investors included Imperial Innovations ; NPI Ventures; London Technology Fund...
Items per page:
1 - 3 of 3